Document Detail


Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial.
MedLine Citation:
PMID:  23425539     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Aims: To examine outcomes in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) at US sites versus sites outside the US (OUS). Methods and results: In the HORIZONS-AMI trial 3,602 STEMI patients in 11 countries were randomised to primary PCI with bivalirudin versus heparin + glycoprotein IIb/IIIa inhibitors. US patients (n=814) had more diabetes, prior infarction, prior bypass surgery, and renal insufficiency. OUS patients (n=2,788) had longer door-to-balloon times, more radial access, fewer bypass surgeries, and were discharged more often on beta-blockers and statins. At three years US patients had higher mortality (9.7% vs. 6.0%, p=0.0003), reinfarction (10.2% vs. 6.4%, p=0.001), major adverse cardiac events (MACE; 28.2% vs. 20.1%, p<0.0001), major bleeding (16.9% vs. 6.4%, p<0.0001) and net adverse clinical events (NACE; 36.6% vs. 23.8%, p<0.0001), which persisted after adjusting for baseline risk. Conclusions: In the HORIZONS-AMI trial, STEMI patients undergoing primary PCI at US versus OUS sites had higher rates of adverse events, which persisted after adjusting for baseline risk. The reasons for these differences are not clear but may be due to unmeasured confounders, different thresholds for event reporting, or valid differences in systems of care and treatments. Registration: ClinicalTrials.gov number NCT00433966.
Authors:
Patrick Tobbia; Bruce R Brodie; Bernhard Witzenbichler; Chris Metzger; Giulio Guagliumi; Jennifer Yu; Mirle A Kellett; Thomas Stuckey; Martin Fahy; Roxana Mehran; Gregg W Stone
Related Documents :
24619969 - Long-term safety and efficacy of second-generation everolimus-eluting stents compared t...
23524989 - Failure to improve door-to-needle time by switching to emergency physician-initiated th...
24337919 - Transportation to primary percutaneous coronary intervention, compared with on-site fib...
24290659 - Excimer laser lesion modification to expand non-dilatable stents: the ellement registry.
7923749 - Temporal electrical heterogeneity for detecting coronary artery disease: results in a h...
24486659 - Thin-strut drug-eluting stents are more favorable for severe calcified lesions after ro...
11486209 - Minimal-access surgery for congenital heart defects.
21802749 - Performance of electrocardiographic criteria to differentiate takotsubo cardiomyopathy ...
21908159 - Association of rate-controlled persistent atrial fibrillation with clinical outcome and...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology     Volume:  8     ISSN:  1969-6213     ISO Abbreviation:  EuroIntervention     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-02-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101251040     Medline TA:  EuroIntervention     Country:  France    
Other Details:
Languages:  eng     Pagination:  1134-42     Citation Subset:  IM    
Affiliation:
LeBauer Cardiovascular Research Foundation and Moses Cone Hospital, Greensboro, NC, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Deferred stent implantation in patients with ST-segment elevation myocardial infarction: a pilot stu...
Next Document:  An international survey of clinical practice during primary percutaneous coronary intervention for S...